(Q46911427)

English

Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide

scientific article published in January 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

immunohistochemistry

1 reference

based on heuristic

inferred from title

pituitary adenoma

1 reference

based on heuristic

inferred from title

author name string

Mao Takei

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Masanori Suzuki

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Hanako Kajiya

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Yudo Ishii

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Shigeyuki Tahara

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Takashi Miyakoshi

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Noboru Egashira

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Susumu Takekoshi

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Naoko Sanno

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Akira Teramoto

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Robert Yoshiyuki Osamura

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Endocrine Pathology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

18

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

208-216

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-007-9004-0

21 January 2018

Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome

1 reference

https://api.crossref.org/works/10.1007%2FS12022-007-9004-0

21 January 2018

Insulin and growth hormone stimulate somatostatin receptor (SSTR) expression by inducing transcription of SSTR mRNAs and by upregulating cell surface SSTRs.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-007-9004-0

21 January 2018

Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: preferential expression of somatostatin receptor subtype 3.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-007-9004-0

21 January 2018

The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of clinical outcome and survival in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited predictive value of an acute test with subcutaneous octreotide for long-term IGF-I normalization with Sandostatin LAR in acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogs in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure and function of somatostatin receptors in growth hormone control.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of somatostatin receptor subtype (SSTR1–5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial tachyphylaxis to somatostatin (SST) analogues in a patient with acromegaly: the role of SST receptor desensitisation and circulating antibodies to SST analogues

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific somatostatin receptors on human pituitary adenoma cell membranes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing mortality in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of acromegaly with sandostatin: the predictive value of an acute test, the value of serum somatomedin-C measurements in dose adjustment and the definition of a biochemical 'cure'

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-year follow-up results of transsphenoidal microsurgery in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for cure of acromegaly: a consensus statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for acromegaly management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of efficacy of octreotide therapy in patients with acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathophysiological consequences of somatostatin receptor internalization and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of pasireotide and octreotide on lymphocyte activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor signaling and endocytosis are differentially regulated by somatostatin analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An audit of outcome of treatment in acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12022-007-9004-0

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

release_6tdzolqvujca5nn4mygteiewdu

1 reference

https://api.fatcat.wiki/v0/release/6tdzolqvujca5nn4mygteiewdu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987403

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46911427&oldid=2208241296"